• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缬沙坦和奈必洛尔治疗对高血压患者中 ADMA 和 pentraxin-3 水平的影响。

The effect of valsartan and nebivolol treatment on ADMA and pentraxin-3 levels in hypertensive patients.

机构信息

Department of Family Medicine, Agri Military Hospital, Agri, Turkey.

出版信息

Med Hypotheses. 2012 Sep;79(3):294-8. doi: 10.1016/j.mehy.2012.05.011. Epub 2012 Jun 13.

DOI:10.1016/j.mehy.2012.05.011
PMID:22698960
Abstract

Long pentraxin 3 (PTX3) is a recently discovered multimeric inflammatory mediator that is structurally linked to short pentraxins, such as C-reactive protein (CRP) and serum amyloid P component. PTX3 is produced by a variety of tissues and cells, including vascular endothelial cells and macrophages. Because of its extrahepatic synthesis (in contrast to CRP), the PTX3 level is believed to be a true independent indicator of disease activity because PTX3 is produced at sites of inflammation and is intimately linked to endothelial dysfunction. PTX3 also has key functions in innate immunity and has been identified in atherosclerotic lesions. Previously, PTX3 was associated with myocyte damage in myocardial infarction (MI), mortality after MI, and unstable angina. Because PTX3 release is likely a specific response to vascular damage, PTX3 levels may provide more explicit information on development and progression of atherosclerosis than nonspecific markers like CRP and interleukin-6. Asymmetric dimethylarginine (ADMA) is a naturally occurring component of human blood plasma. More than one decade ago ADMA was first reported to exert biological effects by inhibiting nitric oxide synthesis. Many researchers today agree that ADMA may play a prominent role in the pathogenesis and in the progression of cardiovascular diseases. In this study PTX3 and ADMA levels investigated of valsartan and nebivolol's effect on newly diagnosed hypertensive patients.

摘要

长型五聚素 3(PTX3)是一种最近发现的多聚体炎症介质,其结构与短五聚素(如 C 反应蛋白(CRP)和血清淀粉样蛋白 P 成分)相关联。PTX3 由多种组织和细胞产生,包括血管内皮细胞和巨噬细胞。由于其在肝外合成(与 CRP 相反),PTX3 水平被认为是疾病活动的真正独立指标,因为 PTX3 在炎症部位产生,与内皮功能障碍密切相关。PTX3 在先天免疫中也具有关键功能,并在动脉粥样硬化病变中被识别。此前,PTX3 与心肌梗死(MI)中的心肌细胞损伤、MI 后的死亡率和不稳定型心绞痛有关。由于 PTX3 的释放可能是对血管损伤的特定反应,因此 PTX3 水平可能比 CRP 和白细胞介素-6 等非特异性标志物提供关于动脉粥样硬化发展和进展的更明确信息。不对称二甲基精氨酸(ADMA)是人类血浆中的一种天然成分。十多年前,ADMA 首次被报道通过抑制一氧化氮合成来发挥生物学作用。今天,许多研究人员都认为 ADMA 可能在心血管疾病的发病机制和进展中发挥突出作用。在这项研究中,研究了缬沙坦和比索洛尔对新诊断的高血压患者的 PTX3 和 ADMA 水平的影响。

相似文献

1
The effect of valsartan and nebivolol treatment on ADMA and pentraxin-3 levels in hypertensive patients.缬沙坦和奈必洛尔治疗对高血压患者中 ADMA 和 pentraxin-3 水平的影响。
Med Hypotheses. 2012 Sep;79(3):294-8. doi: 10.1016/j.mehy.2012.05.011. Epub 2012 Jun 13.
2
The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients.缬沙坦和氨氯地平对新发高血压患者血管微炎症的比较影响。
Clin Exp Hypertens. 2013;35(6):418-23. doi: 10.3109/10641963.2012.739237. Epub 2012 Nov 13.
3
Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.奈必洛尔治疗可降低原发性高血压患者血清不对称二甲基精氨酸水平并改善内皮功能障碍。
Am J Hypertens. 2008 Nov;21(11):1251-7. doi: 10.1038/ajh.2008.260. Epub 2008 Sep 4.
4
Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation.联合应用肾素-血管紧张素系统和钙通道阻滞剂治疗 2 型糖尿病伴蛋白尿高血压患者:对可溶性 TWEAK、PTX3 和血流介导的舒张功能的影响。
Clin J Am Soc Nephrol. 2010 Jul;5(7):1174-81. doi: 10.2215/CJN.01110210. Epub 2010 Apr 29.
5
The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension.坎地沙坦对原发性高血压患者血浆中作为内皮功能障碍标志物的五聚素3水平的影响。
Ir J Med Sci. 2017 Aug;186(3):621-629. doi: 10.1007/s11845-017-1580-5. Epub 2017 Feb 21.
6
Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.比索洛尔和缬沙坦固定剂量复方治疗高血压的疗效和安全性:一项随机、多中心研究。
Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0.
7
Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.奈必洛尔和美托洛尔治疗对2型糖尿病高血压患者血清不对称二甲基精氨酸水平的影响。
Anadolu Kardiyol Derg. 2007 Dec;7(4):383-7.
8
[Comparative effects of nebivolol and valsartan on atrial electromechanical coupling in newly diagnosed stage 1 hypertensive patients].奈必洛尔和缬沙坦对新诊断的1期高血压患者心房机电耦合的比较效应
Turk Kardiyol Dern Ars. 2011 Oct;39(7):563-7. doi: 10.5543/tkda.2011.01585.
9
Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.奈必洛尔与缬沙坦固定剂量复方制剂治疗高血压
Expert Opin Pharmacother. 2015 Apr;16(5):763-70. doi: 10.1517/14656566.2015.1020790.
10
Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study.
J Am Soc Hypertens. 2014 Dec;8(12):915-20. doi: 10.1016/j.jash.2014.09.017. Epub 2014 Sep 28.

引用本文的文献

1
Effect of nebivolol monotherapy or combination therapy on blood pressure levels in patients with hypertension: an updated systematic review and multilevel meta-analysis of 91 randomized controlled trials.奈必洛尔单药治疗或联合治疗对高血压患者血压水平的影响:对91项随机对照试验的最新系统评价和多水平荟萃分析
High Blood Press Cardiovasc Prev. 2025 Jan;32(1):7-31. doi: 10.1007/s40292-024-00687-5. Epub 2024 Oct 29.
2
Involvement of pentraxin-3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats.Pentraxin-3 参与雄性自发性高血压大鼠高血压的发展,但不参与左心室肥厚的发展。
Physiol Rep. 2024 Oct;12(20):e70086. doi: 10.14814/phy2.70086.
3
Postmortem plasma pentraxin 3 is a useful marker of fatal acute coronary syndrome.
死后血浆五聚素 3 是致命性急性冠状动脉综合征的有用标志物。
Sci Rep. 2019 May 30;9(1):8090. doi: 10.1038/s41598-019-44472-0.
4
Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease.五聚素3是非酒精性脂肪性肝病患者纤维化和动脉僵硬度的预测指标。
Gastroenterol Res Pract. 2016;2016:1417962. doi: 10.1155/2016/1417962. Epub 2016 Feb 22.
5
Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection.血清淀粉样蛋白A3作为全身炎症或感染患者的预后生物标志物。
Mediators Inflamm. 2014;2014:421429. doi: 10.1155/2014/421429. Epub 2014 Nov 3.
6
Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.循环五聚素 3(PTX3)的宿主保护作用及其与中性粒细胞胞外诱捕网的复合物形成。
Front Immunol. 2012 Dec 13;3:378. doi: 10.3389/fimmu.2012.00378. eCollection 2012.